# Ingenox Therapeutics Limited

## Details

- **Company number:** [14127227](https://find-and-update.company-information.service.gov.uk/company/14127227)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 24 May 2022
- **Registered office:** MAGDALEN CENTRE ROBERT ROBINSON AVENUE, OXFORD SCIENCE PARK, OXFORD, OX4 4GA
- **Nature of business:** [64209](/sic/64209) Activities of other holding companies n.e.c., [72110](/sic/72110) Research and experimental development on biotechnology


## Previous names

- Celleron Therapeutics Holdings Limited (until 26 Jan 2023)




## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Patrick Soon-Shiong | voting-rights-50-to-75-percent, right-to-appoint-and-remove-directors | 19 Apr 2024 |  |
| Prof Nicholas Barrie La Thangue | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 24 May 2022 | 22 Dec 2022 |



## Accounts

| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2025 | -£9,665,953 | £356,895 | 0 |
| 31 Dec 2024 | -£5,206,795 | £1,040,043 | 0 |




## Controls

- [Argonaut Therapeutics Limited](/company/09993166) (09993166)
- [Celleron Therapeutics Limited](/company/05162047) (05162047)




## Companies at the same address

- [Argonaut Therapeutics Limited](/company/09993166) (09993166)
- [Celleron Therapeutics Limited](/company/05162047) (05162047)
- [Prophase Development Limited](/company/05167257) (05167257)